Challenges in beta(3)-adrenoceptor agonist drug development

被引：95

作者：

Arch, Jonathan R. S. ^{[1
]}

机构：

[1] Univ Buckingham, Clore Lab, Hunter St, Buckingham MK18 1EG, England

来源：

THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM | 2011年 / 2卷 / 02期

关键词：

D O I：

10.1177/2042018811398517

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：59 / 64

页数：6

共 56 条

[1]

Arch J. R. S., 2011, HDB EXPT PH IN PRESS

[2] The discovery of drugs for obesity, the metabolic effects of leptin and variable receptor pharmacology:: perspectives from β3-adrenoceptor agonists [J].

Arch, Jonathan R. S. .

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2008, 378 (02) :225-240

[3] THE BROWN ADIPOCYTE BETA-ADRENOCEPTOR [J].

ARCH, JRS .

PROCEEDINGS OF THE NUTRITION SOCIETY, 1989, 48 (02) :215-223

[4] β3-adrenoceptor agonists:: potential, pitfalls and progress [J].

Arch, JRS .

EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 440 (2-3) :99-107

[5] ATYPICAL BETA-ADRENOCEPTOR ON BROWN ADIPOCYTES AS TARGET FOR ANTI-OBESITY DRUGS [J].

ARCH, JRS ;

AINSWORTH, AT ;

CAWTHORNE, MA ;

PIERCY, V ;

SENNITT, MV ;

THODY, VE ;

WILSON, C ;

WILSON, S .

NATURE, 1984, 309 (5964) :163-165

[6] BETA(3)-ADRENOCEPTOR AND ATYPICAL BETA-ADRENOCEPTOR [J].

ARCH, JRS ;

KAUMANN, AJ .

MEDICINAL RESEARCH REVIEWS, 1993, 13 (06) :663-729

[7] Do low-affinity states of β-adrenoceptors have roles in physiology and medicine? [J].

Arch, JRS .

BRITISH JOURNAL OF PHARMACOLOGY, 2004, 143 (05) :517-518

[8]

ARCH JRS, 1984, INT J OBESITY, V8, P1

[9] beta(3) Receptors: role in cardiometabolic disorders [J].

Bhadada, Shraddha V. ;

Patel, Bhoomika M. ;

Mehta, Anita A. ;

Goyal, Ramesh K. .

THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2011, 2 (02) :65-79

[10] Evidence against β3-adrenoceptors or low affinity state of β1-adrenoceptors mediating relaxation in rat isolated aorta [J].

Brahmadevara, N ;

Shaw, AM ;

MacDonald, A .

BRITISH JOURNAL OF PHARMACOLOGY, 2003, 138 (01) :99-106

← 1 2 3 4 5 6 →